Severe secondary immune thrombocytopenia in a patient with chronic lymphocytic leukemia
Article Properties
-
DOI (url)
-
Publication Date2022/05/16
-
Journal
-
Indian UGC (journal)
-
Refrences21
-
Dominika Écsiová
-
Pavel Vodárek
-
Petra Rozsívalová
-
Filip Vrbacký
-
Kateřina Hrochová
-
Petr Hoffmann
-
Pavel Žák
-
Lukáš Smolej
-
Martin Šimkovič
Cite
Écsiová, Dominika, et al. “Severe Secondary Immune Thrombocytopenia in a Patient With Chronic Lymphocytic Leukemia”. Onkologie, vol. 16, no. 3, 2022, pp. 151-4, https://doi.org/10.36290/xon.2022.029.
Écsiová, D., Vodárek, P., Rozsívalová, P., Vrbacký, F., Hrochová, K., Hoffmann, P., Žák, P., Smolej, L., & Šimkovič, M. (2022). Severe secondary immune thrombocytopenia in a patient with chronic lymphocytic leukemia. Onkologie, 16(3), 151-154. https://doi.org/10.36290/xon.2022.029
Écsiová D, Vodárek P, Rozsívalová P, Vrbacký F, Hrochová K, Hoffmann P, et al. Severe secondary immune thrombocytopenia in a patient with chronic lymphocytic leukemia. Onkologie. 2022;16(3):151-4.
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Doporučení pro diagnostiku a léčbu chronické lymfocytární leukemie. TaH | 2021 | |||
Successful Long-Term Use of Eltrombopag in a Patient with Refractory Severe Thrombocytopenia Associated with Chronic Lymphocytic Leukemia That Allowed Oral Anticoagulant Treatment for Severe Cardiomyopathy | Case Reports in Hematology |
| 1 | 2017 |
Eltrombopag for resistant immune thrombocytopenia secondary to chronic lymphocytic leukaemia | Internal Medicine Journal |
| 7 | 2014 |
| A phase II trial of eltrombopag for patients with chronic lymphocytic leukaemia (CLL) and thrombocytopenia | British Journal of Haematology |
| 8 | 2018 |
| 10.1056/NEJMoa073275 |